Literature DB >> 27468723

Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.

Senjun Zhou1, Jiliang Shen1, Shuang Lin1, Xiaolong Liu1, Ming Xu1, Liang Shi1, Xianfa Wang1, Xiujun Cai2.   

Abstract

Dishevelled-Axin domain containing 1 (DIXDC1) is a DIX (Dishevelled-Axin) domain possessing protein that acts as a positive regulator of the Wnt pathway. Although DIXDC1 has been investigated in several cancers, it has not yet been studied in human hepatocellular carcinoma (HCC). The purpose of the current study was to investigate the expression pattern of DIXDC1 and assess the clinical significance of DIXDC1 expression in HCC patients. Data containing three independent investigations from Oncomine database demonstrated that DIXDC1 mRNA was downregulated in HCC compared with matched non-cancerous tissues. Similar results were also obtained in 25 paired HCC tissues and corresponding non-cancerous tissues by qPCR and Western blot analysis. Additionally, another independent set of 140 pairs of HCC specimens was evaluated for DIXDC1 expression by IHC and demonstrated that reduced expression of DIXDC1 in 50.7 % (71/140) of HCC tissues was significantly correlated with tumor size (p = 0.024), tumor differentiation (p < 0.001), tumor thrombi (p = 0.019), TNM stage (p = 0.019), and BCLC stage (p = 0.008). Importantly, Kaplan-Meier survival and Cox regression analyses were executed to evaluate the prognosis of HCC patients and found that DIXDC1 protein expression was one of the independent prognostic factors for overall survival of HCC patients.

Entities:  

Keywords:  DIXDC1; Hepatocellular carcinoma; Prognosis; Survival

Mesh:

Substances:

Year:  2016        PMID: 27468723     DOI: 10.1007/s13277-016-5213-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

2.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

3.  DIXDC1 co-localizes and interacts with gamma-tubulin in HEK293 cells.

Authors:  Yanrui Wu; Xiaotang Jing; Xin Ma; Yan Wu; Xuefeng Ding; Wenhong Fan; Ming Fan
Journal:  Cell Biol Int       Date:  2009-04-16       Impact factor: 3.612

Review 4.  FAK signaling in human cancer as a target for therapeutics.

Authors:  Brian Y Lee; Paul Timpson; Lisa G Horvath; Roger J Daly
Journal:  Pharmacol Ther       Date:  2014-10-12       Impact factor: 12.310

Review 5.  Staging of hepatocellular carcinoma.

Authors:  Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

6.  Wnt signaling stabilizes the DIXDC1 protein through decreased ubiquitin-dependent degradation.

Authors:  Lei Wang; Hua Li; Qi Chen; Tengfang Zhu; Hongguang Zhu; Li Zheng
Journal:  Cancer Sci       Date:  2009-11-23       Impact factor: 6.716

7.  DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.

Authors:  Lei Wang; Xi-Xi Cao; Qi Chen; Teng-Fang Zhu; Hong-Guang Zhu; Li Zheng
Journal:  Cancer Sci       Date:  2009-06-17       Impact factor: 6.716

8.  DIXDC1 increases the invasion and migration ability of non-small-cell lung cancer cells via the PI3K-AKT/AP-1 pathway.

Authors:  Zhonghai Xu; Di Liu; Chuifeng Fan; Lan Luan; Xiupeng Zhang; Enhua Wang
Journal:  Mol Carcinog       Date:  2013-06-29       Impact factor: 4.784

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Upregulated expression of DIXDC1 in intestinal-type gastric carcinoma: co-localization with β-catenin and correlation with poor prognosis.

Authors:  Lei Wang; Cong Tan; Fan Qiao; Weige Wang; Xiangnan Jiang; Peng Lian; Bin Chang; Weiqi Sheng
Journal:  Cancer Cell Int       Date:  2015-12-18       Impact factor: 5.722

View more
  3 in total

1.  Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.

Authors:  Xuanyi Che; Yuanjie Qian; Di Li
Journal:  J Mol Neurosci       Date:  2017-12-20       Impact factor: 3.444

2.  Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients.

Authors:  Wei Wen; Baohong Jiang; Xi Cao; Liming Xie; Xiaoli Zhang; Yuehua Li; Rongfang He
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

3.  DIX domain containing 1 (DIXDC1) modulates VEGFR2 level in vasculatures to regulate embryonic and postnatal retina angiogenesis.

Authors:  Yeaji Kim; Dong Young Kim; Haiying Zhang; Cho-Rong Bae; Daehyeon Seong; Yeomyung Kim; Jaewhan Song; Young-Myeong Kim; Young-Guen Kwon
Journal:  BMC Biol       Date:  2022-02-10       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.